1Diebold S S, Montoya M, Unger H et al. Viral infection switches nonplasmacytoid dendritic cells into high interferon producers [J]. Nature,2003; 424(6946): 324-328.
2Hoshino K, Takeuchi O, Kawai T et al. Cutting edge:Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product [J]. J Immunol, 1999; 162(7): 3749-3752.
3Doyle S, Vaidya S, O' Connell R et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program [J]. Immunity,2002; 17(3): 251-263.
4Ohmori Y, Hamilton T A. Requirement for STAT1 in LPS-induced gene expression in macrophages [J]. J Leukoc Biol,2001; 69(4): 598-604.
5Hertzog P J, O'Neill L A,Hamilton J A. The interferon in TLR signaling:more than just antiviral [J]. Trends Immunol,2003; 24(10): 534-539.
6Hamilton J A, Whitty G A, Kola I et al. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha [J].J Immunol, 1996; 156(7): 2553-2557.
7Portnoy D A, Auerbuch V, Glomski I J. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity [J]. J Cell Biol,2002; 158(3): 409-414.
8Janeway C A, Jr Medzhitov R. Innate immune recognition [ J]. Annu Rev Immunol,2002;20:197-216.
9Vaidya S A, Cheng G. Toll-like receptors and innate antiviral responses [J]. Curr Opin Immunol,2003; 15(4) :402-407.
10Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling [J]. Nature,2004;430(6996) :257-263.
